drugset / Trial / NCT05350852
Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With MRD+ B-ALL
Non-randomizedSequentialOpen-labelTreatment
Summary
This is an open label, phase I study to assess the safety, efficacy and pharmacokinetics of ThisCART19A in patients with MRD+ B-ALL
Timeline
- Start
- 2022-03-18
- Primary completion
- 2024-03-30
- Completion
- 2024-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ThisCART19A | Cell therapy | 5e+06 cells/kg | — |
| Subject | ThisCART19A | Cell therapy | 8e+06 cells/kg | — |
| Subject | ThisCART19A | Cell therapy | 1.2e+07 cells/kg | — |
Indications
No indication recorded.